Katharina Kiesel joined Immatics in 2016 and is overseeing and coordinating project management activities at Immatics for proprietary and partnered programs. She is also project lead of Immatics’ TCR bispecifics program IMA401.
Before joining Immatics, Katharina gained experience in oncology research at the German Cancer Research Center (DKFZ) in Heidelberg.
At Immatics, Katharina has successfully led cross-functional teams in partnered as well as proprietary preclinical and clinical programs and was involved in drug development during the transition from preclinical to clinical phase.
Katharina holds a Master of Science in Molecular Biotechnology from the University of Heidelberg and performed her PhD studies at the DKFZ in Heidelberg.